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ABSTRACT
This paper describes the first immunosensing system reported for the detection of 
bacteria combining immunomagnetic capture and amperometric detection in a one-
step sandwich format, and in a microfluidic environment. Detection is based on the 
electrochemical monitoring of the activity of horseradish peroxidase (HRP), an
enzyme label, through its catalysis of hydrogen peroxide (H2O2) in the presence of 
the mediator hydroquinone (HQ). The enzymatic reaction takes place in an 
incubation micro-chamber where the magnetic particles (MP) are confined, 
upstream from the working electrode. The enzyme product is then pumped along a 
microchannel, where it is amperometrically detected by a set of microelectrodes. 
This design avoids direct contact of the biocomponents with the electrode, which 
lowers the risk of electrode fouling. The whole assay can be completed in 1 hour. 
The experiments performed with E. coli evidenced a linear response for 
concentrations ranging 102-108 cell ml-1, with a limit of detection of 55 cells ml-1 in 
PBS, without pre-enrichment steps. Furthermore, 100 cells ml-1 could be detected in 
milk, and with negligible interference by non-target bacteria such as Pseudomonas.
Keywords 
Amperometric immunosensor; bacteria detection; immunomagnetic capture; 
microfluidic system; electrochemical detection.
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1. Introduction
Bacteria detection is a permanent concern in a wide range of fields, including the 
food, pharmaceutical and water treatment industries, in which fast detection is 
critical to prevent microbial outbreaks. Milk is one of the media where foodborne 
pathogens thrive, and in the past it has been the origin of diseases such as 
tuberculosis, brucellosis, diphtheria, and scarlet fever (Vasavada 1988; Baylis 2009). 
The risk of outbreaks has been significantly reduced thanks to the modern 
production practices, including sanitary control of the herds, appropriate handling, 
cooling and storage conditions, and specially pasteurization. Nevertheless, 
contaminated milk can reach the consumer in cases of incomplete pasteurization, 
innadequate storing, and/or post-processing contamination. For example, an 
outbreak detected in Austria in June 2007 afected 40 children who had consumed 
pasteurized milk products (Schmid et al., 2009). And milk or milk products were 
suspected to cause 177 outbreaks in France between 1988-1997 (De Buyser et al., 
2001). Accordingly, there is a strong necessity for developing sensitive and accurate 
biosensors and portable lab-on-a-chip devices capable of rapid and versatile analyses 
(G. Ocvirk et al., 1998; E. T. Lagally et al., 2004; N. Beyor et al., 2008). 
Escherichia coli is the model microorganism most widely used in biosensing 
development. This is due to its ubiquity, and because E. coli is responsible for 
numerous water- and food-transmitted infections (P. M. Griffin and Tauxe 1991; F. 
Perez et al., 2001; J. H. Thomas et al., 2003; H. S. Hussein and Bollinger 2005).
Immunofunctionalised magnetic particles (MP) and immunomagnetic separation 
(IMS) have been proposed as new and versatile tools for biosensing (Hsing et al., 
2007; Jaffrezic-Renault et al., 2007). Using MP allows fast, simple, and specific pre-
concentration of target bacteria from relatively large and dilute sample volumes, as 
well as physical separation from non-target components occurring in complex 
sample matrices. In addition, MP provide large surface areas which, in combination 
with rotation with the sample, generate enhanced target-antibody kinetics, shorter 
assay times, and improved limits of detection (LOD) (Hsing et al., 2007; Jaffrezic-
Renault et al., 2007). Bacteria detection on MP has been usually based on classical 
sandwich assay formats, in which bacterial IMS is followed by detection using a 
labeled-antibody (Ab). Mainly coupled to colorimetric, fluorescent or 
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chemiluminiscent detection, those assays had reported LODs of 103-106 cell ml−1
within assay times of 1-2 h, and could be carried out even in real sample matrices 
such as water or milk (Nakamura et al., 1993; Bruno et al., 1996; Yu 1998; Yu et al., 
2000; Tu et al., 2001; Tu et al., 2003; Gehring et al., 2006; Baldrich and Muñoz 
2008).
MP offer an additional advantage: the possibility to integrate IMS and 
microfluidics technology (Gijs et al., 2010). Microfluidic systems enable the 
analysis of small sample volumes, as well as the utilization and disposal of minute 
amounts of reagents. The integration of several assay steps in-chip facilitates and 
accelerates manipulation. In addition, operation under flow conditions improves 
immunocapture, enzymatic reactions and electrochemical detection by minimising 
the limitation of mass transport, contributing to reduce assay time. At least one work 
reports on a flow-through immunomagnetic separator designed to capture bacteria 
from large volume samples (>50 ml) (Rotariu et al., 2005) and an increasing number 
of publications describe the automation of MP manipulation, recovery, and/or 
detection (Herrmann et al., 2008; Hervas et al., 2009; Peyman et al., 2009; Yoon et 
al., 2009; Berti et al., 2009 ; Johansson et al., 2010). However,  only a few cases 
describe the application to immunocapture and detection of whole bacterial cells 
(Chandler et al., 2001; Straub et al., 2005; Qiu et al., 2009; Ramadan et al., 2010).
For example, Qiu employed a U-shaped microchannel with two magnets to entrap 
immunofunctionalised MP (Qiu et al., 2009), which granted specific capture of the 
target microorganisms. MP were then eluted and fluorescent detection of bacterial 
ATP was performed out of the chip. Ramadan reported an original device integrating 
a serpentine channel with rows of rotating magnets (Ramadan et al., 2010). 
Following MP injection, magnet rotation induced their subsequent entrapment and 
release. As a consequence, MP moved along the channel while being washed, and 
provided recovery efficiencies of about 83-90% for Giardia and Cryptosporidium
from tap water samples, and of about 18-36% in spiked secondary effluent water 
samples. Nonetheless, MP immunocapture, bacteria staining, and detection using a 
fluorescence microscope were performed outside the chip. Chadler, on the other 
hand, used a Teflon tube (19.1 mm long x 2.1 mm wide) filled with Ni foam to 
retain immunofunctionalised MP (Chandler et al., 2001). PBS or poultry carcass 
rinse samples, spiked with E. coli, were perfused over the MP in a back-and-forth 
stepped-flow regime, which promoted mixing and extended contact time. After MP 
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release, E. coli was detected by Polymerase Chain Reaction (PCR) down to an initial 
concentration of 103 cell ml-1. The latter integration of a flow-through PCR reaction 
chamber, followed by elution and off-line microarray hybridisation and fluorescent 
detection, provided identification of 10 E. coli cells spiked in 1 ml of water in the 
absence of interferent bacteria (Straub et al., 2005).
Here we apply a simple, reusable and portable electroanalytical microchannel flow 
cell to detection of pathogen bacteria. First, a classical two-step sandwich ELISA is 
formatted into a one-step sandwich immunomagnetic assay. Thus assay time is 
shortened and sample manipulation is simplified without negatively affecting 
detectability. MP are then analysed using a flow cell (Figure 1), which encloses an 
incubation microchamber, a microfluidic channel, and a silicon chip containing a set 
of electrodes (Godino et al., 2010). While MP are magnetically retained in the
microchamber, the enzyme product flows and is chronoamperometrically detected at 
the gold microband electrode located downstream. Capturing the MP upstream from 
the microelectrodes presents an innovation over the general trend to capturing them 
directly over the electrodes (Choi et al., 2002; Do and Ahn 2008): it provides better 
control over the mass transport conditions, which leads to higher currents, and 
protects the electrode surface from fouling and passivation.
Under these conditions, the specific detection of E. coli was successful in a 
concentration range between 102-108 cell ml-1 with an LOD of 55 cell ml-1 and little 
interference by non-target Pseudomonas. Furthermore, 100 cell ml-1 of E. coli were 
consistently detected in 10% milk. These results demonstrate the value of this 
combination of immunomagnetic capture, electrochemical detection, and 
microfluidic technology for the detection of pathogen bacteria even in complex 
sample matrices.
2. Materials and methods
2.1. Chemical reagents and biocomponents
Phosphate Buffered Saline 0.01 M tablets (PBS), streptavidin-coated Dynabeads 
(M-270, 2.8 µm diameter), and biotinylated horseradish peroxidase (HRP) were 
obtained from Invitrogen (Barcelona, Spain). Biotinylated and HRP-labelled anti-E. 
coli polyclonal Ab were respectively purchased from AbCam (Cambridge, UK) and 
US Biological (Massachusetts, USA). Hydroquinone (HQ), 3,3’,5,5’-
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Tetramethylbenzidine liquid substrate system (TMB), KCl, KNO3, 
K4Fe(CN)6.3H2O, K3Fe(CN)6, p-benzoquinone (BQ) and hydrogen peroxide (30%) 
were purchased from Sigma (Barcelona, Spain).
2.2. Preparation and handling of bacteria
Escherichia coli K12 and Pseudomonas putida KT 2442 were obtained from the 
American Type Cells Collection. Bacteria were grown overnight in Luria-Bertani 
(LB) liquid medium at 37ºC. The cultures were serially diluted and agar plated to 
obtain the viable counts (colony-forming units [CFU]). The cultures were then 
aliquoted into eppendorf tubes and centrifuged for 10 minutes at 12000 rpm. The 
supernatants were discarded, and ready-to-use pellets were stored at -20 ºC until 
needed (Baldrich et al., 2008). Before reconstitution, frozen pellets were temperated
at 4 ºC for 10 minutes. The pellets were re-suspended in 50 µl of the desired solution
and, after agitation and complete re-suspension, the volume was completed to 1 ml.
2.3. Functionalisation of MP
Two types of customized MP, enzyme-modified MP and anti-E. coli MP, were 
prepared by modifying streptavidin-coated Dynabeads with biotinylated HRP and 
biotinylated anti-E. coli polyclonal Ab respectively (approximately 3.3 µg of HRP 
or 1 µg of Ab per 7 x 106 MP). Briefly, protein and MP were agitated for 30 min at 
room temperature, washed with PBS containing 0.1% (v/v) Tween 20 (PBS-T), 
treated with biotin excess for 5 min in order to block the remaining biotin-binding 
sites, and stored until used at 4ºC (approximately 7 × 108 MP ml−1) in PBS 
containing 0.1% bovine serum albumin (BSA).
2.4. Sandwich immunoassay on MP
Immediately prior to assay performance, the anti-E. coli MP were completely 
resuspended by vortexing for 1–2 minutes. Bacteria were serially diluted in PBS 
containing 0.01% Tween 20. Approximately 7 × 106 MP and 4 µg of HRP-labelled 
anti-E.coli Ab were added per ml of sample. The samples were then rotated for 40 
minutes at room temperature, concentrated using a magnet (BILATEST; Bilatec AG; 
Stuttgart, Germany), and washed twice with PBS-T for 5 minutes in continuous 
Page 7 of 22
Ac
ce
pte
d M
an
us
cri
pt
7
rotation.
2.5 Spectrophotometric measurements
For the colorimetric detection of the sandwich immunoassay, MP were 
resuspended in 15 µl PBS-T, transferred to a microtitter plate, and TMB was added 
(100 µl per well). After 25 minutes, the enzymatic reaction was stopped with 100 µl 
H2SO4 0.1 M per well and absorbance was measured at 450 nm.
2.6. Electrochemical measurements using the microfluidic system
The HRP substrate/mediator solution contained 1 mM H2O2 and 1 mM HQ in 
deoxygenated PBS (pH 7). The composition and pH of this substrate solution was
optimised experimentally (data not shown).
MP were resuspended in 400 µl PBS pH7 and 200 µl were injected in the 
microfluidic cell at 50 µl min-1. The cell was then filled with 100 µl of 
substrate/mediator solution, the flow rate was stopped and the enzyme was allowed 
to react with the substrate for 5 minutes. Finally, the substrate flow was resumed at 
10 µl min−1 and the current was measured at -0.35 V using a CHI700C bipotentiostat 
(CH Instruments, Texas, USA). The whole system was extensively washed between 
measurements by flowing PBS in order to avoid sample cross-contamination.
The microband gold electrodes were fabricated using standard photolithographic 
techniques. Briefly, a 50-nm adhesion layer of Ti and a 200 nm layer of Au were 
sequentially deposited by e-beam evaporation, and the electrodes were defined by 
lift-off. Each device consisted of three bands 500 µm wide and one band 1 mm wide, 
all parallel and separated from each other by 100 µm gaps. The wider band was used 
as auxiliary electrode. Although the remaining three bands could be indistinctly used 
as working or pseudo-reference electrode, the upstream-most microband was used as 
the pseudo-reference to avoid potential shifts during the measurements. 
The microfluidic system consisted of three components (Figure 1). The bottom (1), 
made of polycarbonate (PC), contained a pocket for housing the chip and two 
magnets to promote confinement of the MP upstream from the electrode. The MP 
could be subsequently released by sliding a metal piece between the magnets and the 
chip, which allowed performing consecutive experiments. The top closure (2), 
fabricated in polymethylmethacrylate (PMMA), featured the fluidic interconnections 
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and a pocket for a polydimethylsiloxane (PDMS) gasket. The solutions were fed in 
and out through blunt syringe needles and spring-loaded pins provided electrical 
connection to the chip. Finally, a PDMS gasket, clamped between 1 and 2, provided 
water-tight sealing and contained all the microfluidic features of the system. These 
consisted of a cavity 2 mm wide, 150 µm high and 5 mm long that sat directly above 
the magnets, exiting to a channel 500 µm wide and of the same height that leads the 
solution out of the system after passing over the electrodes. The flow was controlled 
using a syringe pump, NE1000 (New Era Pump Systems, NY).
2.7. Data analysis
The results presented come from no less than 3 replicates and the error bars 
correspond to the standard deviation of the measurements. The limits of detection 
(LOD) were calculated from the average of the blanks (assay carried out in the 
absence of target bacteria) plus three times their standard deviation.
3. Results and discussion
3.1. Optimisation of the one-step sandwich immunoassay on MP
The optimisation of the sandwich immunoassay on MP was carried out via 
colorimetric detection using TMB as the HRP mediator. With this aim, anti-E. coli
MP were produced and were used to capture increasing concentrations of E. coli. It 
followed washing, incubation with anti-E. coli HRP-Ab, and addition of enzyme 
substrate. After assaying different biocomponent concentrations and incubation 
times, optimal results were obtained for 30-minute immunocaptures with 7 x 106 MP 
ml-1, followed by incubation with 4 µg HRP-Ab for 60 min, and two washes of 5 
min in rotation between each two steps. Under these conditions, the assay detected 
E. coli in a concentration range from 104 to 108 cell ml-1 with an LOD of 3 x 103 cell 
ml-1 (Figure 2a). This is two orders of magnitude below the LOD reported for the 
same Ab set used in a classical ELISA on microtitter plates (Laczka et al., 2008).
Assay shortening was next attempted by combining bacteria immunocapture and 
binding by HRP-Ab in a single assay step. Hence, anti-E. coli MP and HRP-Ab were 
simultaneously added to samples, which were then rotated at room temperature for 
Page 9 of 22
Ac
ce
pte
d M
an
us
cri
pt
9
20-60 minutes. The best results were obtained for a 40-minute incubation time in the 
presence of 4 µg HRP-Ab (Figure 2b). Longer incubations induced higher signals, 
but also higher level of Ab-HRP non-specific adsorption and background noise and 
worse assay LOD. Even if the one-step assay generated lower signals than the two-
step format, the results were comparable in terms of LOD (5 x 103 cells ml-1), and it 
was shorter and easier to perform (Figure 2a).
Figure 2c shows the specificity of the one-step sandwich assay, which was 
determined by comparison between the signals obtained for E. coli (due to specific 
immunocapture) and those obtained for the negative-control bacteria Pseudomonas 
putida (caused by non-specific adsorption). The assay showed low signals over the 
entire Pseudomonas concentration range.
3.2. Electrochemical characterization of the microchannel flow cell
Despite its electroactivity (Volpe et al., 1998; Díaz-González et al., 2005; Fanjul-
Bolado et al., 2005; Baldrich et al., 2009), TMB could not be used in our 
microfluidic system because the reaction product precipitated over the MP, which 
hampered electrochemical detection downstream. Instead, we used 
hydroquinone/benzoquinone (HQ/BQ) (Elyacoubia et al., 2006; Ji et al., 2007).
In this system, HRP catalyses the reduction of hydrogen peroxide (H2O2) coupled 
to the oxidation of HQ into BQ (Eq. 1). BQ is then electrochemically reduced back 
into HQ at the electrode surface (Eq. 2), generating a reduction wave around -0.35 V 
vs. Au.
In the presence of HRP, production of BQ should be directly related to the amount 
of enzyme. To verify this, streptavidin-coated MP were used to capture increasing 
quantities of biotynilated HRP and the HRP-MP were injected into the microfluidic 
cell. The MP were trapped by the magnets on top of the chip, while the solution 
flowed through. Physical obstruction of either tubes or channel by MP aggregates 
was never observed. The cell was then filled with substrate/mediator solution and 
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the flow stopped for 5 minutes to allow the enzyme reaction to proceed. Flow was 
restored and the chronoamperometric measurement started. After each measurement, 
an iron slab was slid between the magnets and the microchannel to block the 
magnetic field, and the whole system was extensively washed by flowing PBS. This 
released the MP, washed away all the enzyme, and prevented crossed contamination 
between samples.
Figure 3a shows the signals obtained for the different HRP concentrations. As 
soon as the flow is restored, the BQ produced over 5 minutes at the HRP-MP is 
carried towards the electrodes. Here, BQ is reduced, resulting in a marked reduction 
peak at the beginning of the measurement. It follows current stabilisation, which is 
an indicator of the actual enzymatic reaction rate. Both the height and width of the 
initial reduction peak and the steady-state current intensity subsequently registered 
were proportional to the quantity of HRP captured on the surface of the HRP-MP.
The study of peaks generated as a result of enzyme product accumulation during 
the transition between flow rates reportedly provided increased sensitivity for β-
galactosidase detection (Godino et al., 2010).  In the HRP-HQ system, however, 
wider peaks and lower initial currents (t=0) were registered for the highest 
concentrations of HRP tested, which indicated that part of the BQ produced diffused 
towards the electrodes during the incubation step. Hence, the initial reduction peak 
was only informative for the study of low-to-medium HRP concentrations. This was 
attributed to the different kinetics of the two enzymes but was not studied further. 
On the contrary, the current values registered at the steady state were reproducible 
over a wide range of HRP concentrations (Figure 3b) and provided an LOD of 1pg 
ml-1 of HRP.
3.3. Detection of E. coli using the one-step immunoassay at the microchannel flow 
cell
 Next, different concentrations of E. coli were assayed using the one-step 
immunoassay coupled to amperometric detection at the flow cell. Performing 
immunomagnetic capture and washing outside the detector chip provided optimal 
mixing and target capture ratios and minimal contact of free biocomponents with the 
microchannel. Only half of each sample was injected into the flow cell (3.5 x 106
MP) because injecting more beads produced uneven distribution on surface and 
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presumably packaging into multi-layers, which affected the reproducibility of the 
assay. Figure 4 shows the currents registered at the steady-state after 250 seconds of 
measurement. E. coli could be detected in a concentration range of 102-108 cells ml-
1, with an LOD of 55 cells ml-1. Simultaneously, the negative controls with no 
bacteria or with non-target Pseudomonas putida evidenced very low levels of both 
non-specific adsorption and antibody crossbinding. For example, the signals 
obtained for 108 cells ml-1 P. putida were always below the signals generated by the 
capture of 102 cells ml-1 of target E. coli. The whole assay, including 40 min of 
immunoassay, 2 washes of 5 min each, injection into the microfluidic system and 
enzyme monitoring, took about 1 h. Hence, the present assay has an LOD 2 and 4 
orders of magnitude below that of the colorimetric ELISA performed on MP and 
microtitter plates respectively, and is 30 minutes shorter.
3.4. Detection in milk samples
In order to assess the performance of the reported method in a more complex 
matrix such as milk, 102 E. coli cells were inoculated in either milk (dissolved to 
10% with PBS) or PBS and were processed as described before. The results are 
summarised in Figure 5. As before, immunocapture and washing were followed by 
magnetic capture of the MP on top of the chip and cell filling with 
substrate/mediator solution. In this case, the flow was stopped to allow the enzyme 
reaction to proceed but the measument started immediately in order to provide 
accurate background signals. After 5 minutes of incubation, flow was restored. 
Again, BQ produced over 5 minutes at the MP moved towards the electrodes and 
was reduced. This resulted in a marked reduction peak, which was followed by 
current stabilisation. The changes in signal measured in the negative controls were 
mainly atributed to non-specific adsorption of HRP-Ab on the MP, also detectable in 
the colorimetric assay.
Despite being subject to larger errors, in the presence of low concentrations of HRP 
the initial current peaks gave higher relative signals than the subsequent steady state 
currents and were proportional to the amount of captured bacteria. The values of the 
current peaks obtained for the MP incubated in PBS were more than twice those 
registered for the MP incubated in 10% milk (on average 26.8 and 12.1 nA 
respectively). Nevertheless, the signal to noise ratio (signal registered for the 
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bacteria-containing sample divided by background signal recorded for the 
corresponding negative control) were of the same order in both PBS and milk 
samples (around 1.6 and 1.7 in that order). Because the electrochemical detection is 
carried out similarly in both cases, the differences rather evidence changes in 
immunocapture efficiency. In this respect, it is known that immunocapture is 
negatively affected in media of increased viscosity, where the ligand diffusion 
coefficient and the Ab/target binding rate are reduced (Baldrich et al., 2008). At the 
same time, the background signals were lower in milk, presumably caused by lower 
levels of  HPR-Ab non-specific adsorption in a richer sample matrix. Regardless of 
this, peak heights were higher in milk samples containing bacteria than in the 
blanks, demonstrating that as little as 100 E. coli cells ml-1 can be detected in this 
sample matrix.
The minimal number of viable E. coli bacteria that can produce disease, known as 
the infectious dose, fluctuates between 104-108 cells, depending on the strain and the 
individual (Kothary and Babu 2001). In the specific case of verotoxigenic E. coli
O157:H7, the infectious dose is lower and just 700 bacteria seem able to cause 
illness (CDC et al., 2004). Nevertheless, current safety regulations require that 
bacterial presence at the end of the elaboration process of milk derivatives is low 
enough to guarantee that microorganism can not growth above hazardous levels over 
storing or post-processing. As an example, the European Union considers 
innacceptable titters of Enterobacteriaceae above 10 cell ml-1 for pasteurized milk, 
and E. coli presence over 100 cell ml-1 for milk that has undergone a lower heat 
treatment than pasteurisation (EU 2005; EU 2010). The described combination of a 
one-step sandwich immunoassay, MP pre-concentration, and microfluidic 
electrochemical detection allows fast, specific, and sensitive detection of bacteria 
even in relatively complex sample matrices. Nevertheless, for the application at 
industrial environments, where the strict requirements of the health authorities have 
to be met, additional sample pre-concentration and/or pre-enrichment strategies 
should be implemented.
4. Conclusions
We have developed a novel electrochemical immunosensing assay for bacterial 
detection that combines a one-step sandwich immunoassay, MP target pre-
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concentration, microfluidic technology, and amperometric detection of the label 
enzyme. The incorporation on a one-step immunoassay contributes to shorten the 
analysis compared to classical two-step sandwich assays without compromising 
detectability. Magnetic pre-concentration makes it possible the study of relatively 
complex sample matrices. The integration of microfluidic technology provides 
versatility and improved sensitivity to the electrochemical detection. Finally, the 
unique design of the chips and flow cell define two connected but independent 
spaces, where the enzymatic and electrochemical reactions take place respectively. 
This characteristic prevents the physical coverage and/or passivation of the working 
electrode by MP or by any biocomponents present in the samples and ensures 
optimal electrode performance.
The results showed that the reported assay detected E. coli in a concentration 
range between 102-108 cell ml-1 with an LOD of 55 cell ml-1 and little interference 
by significantly higher concentrations of non-target Pseudomonas. The whole assay 
takes about 1 hour, including immunoassay, magnetic pre-concentration, washes and 
electrochemical detection. Hence this system provides a significant improvement in 
terms of limit of detection and assay time compared to classical ELISA detection. 
Furthermore, pre-capture of the bacteria within a more complex matrix such as milk 
was also successful which suggests its potential applicability to the food industry, 
pharmaceutical, and medical fields, provided that pre-concentration and/or pre-
enrichment strategies are implemented.
Acknowledgements
This work was funded by the Spanish Ministry of Science and Innovation 
(MICINN) through project grant CTQ2009-08595 (MICROPLATE). JdC 
acknowledges a Ramón y Cajal Fellowship from MICINN.
References
Baldrich, E., del Campo, F.J., Munoz, F.X., 2009. Biosens. Bioelectron. 25(4), 920-926.
Baldrich, E., Muñoz, F.X., 2008. Analyst 133, 1009-1012.
Baldrich, E., Vigues, N., Mas, J., Munoz, F.X., 2008. Analytical Biochemistry 383(1), 
68-75.
Page 14 of 22
Ac
ce
pte
d M
an
us
cri
pt
14
Baylis, C.L., 2009. Int. J. Dairy Technol. 62(3), 293-307.
Berti, F., Laschia, S., Palchetti, I., Rossier, J.S., Reymond, F., Mascinia, M., Marrazza, 
G., 2009 Talanta 77, 971-978.
Bruno, J.G., Yu, H., Kilian, J.P., Moore, A.A., 1996. Journal of Molecular Recognition 
9(5-6), 474-479.
CDC, Centers for Disease Control, American Medical Association, American Nurses 
Association, American Nurses Foundation, Center for Food Safety & Applied 
Nutrition, Food & Drug Administration, Food Safety Inspection Service, and US 
Agriculture Department (2004). Diagnosis and management of foodborne 
illnesses: a primer for physicians and other health care professionals. MMWR 
Recomm Rep. 53: 1-33.
Chandler, D.P., Brown, J., Call, D.R., Wunschel, S., Grate, J.W., Holman, D.A., Olson, 
L., Stottlemyre, M.S., Bruckner-Lea, C.J., 2001. Int. J. Food Microbiol. 70(1-2), 
143-154.
Choi, J.W., Oh, K.W., Thomas, J.H., Heineman, W.R., Halsall, h.B., Helmicki, A.J., 
Henderson, H.T., Ahn, C.H., 2002. Lab Chip 2, 27-30.
De Buyser, M.L., Dufour, B., Maire, M., Lafarge, V., 2001. Int. J. Food Microbiol. 
67(1-2), 1-17.
Díaz-González, M., González-García, M.B., Costa-García, A., 2005. Electroanal. 
17(21), 1901 – 1918.
Do, J., Ahn, C.H., 2008. Lab Chip 8, 542-549.
E. T. Lagally, J. R. Scherer, R. G. Blazej, N. M. Toriello, B. A. Diep, M. Ramchandani, 
G. F. Sensabaugh, L. W. Riley, Mathies, R.A., 2004. Anal. Chem. 76, 3162-
3170.
Elyacoubia, A., Zayeda, S.I.M., Blankert, B., Kauffmann, J.-M., 2006. Electroanal. 
18(4), 345-350.
EU, 2005. EC 2073/2005, Official Journal of the European Union L 338, 1-26.
EU, 2010. EC 365/2010, Official Journal of the European Union L 107, 9-11.
F. Perez, I. Tryland, M. Mascini, Fiksdal, L., 2001. Anal. Chim. Acta. 2, 149-154.
Fanjul-Bolado, P., González-García, M.B., Costa-García, A., 2005. Anal. Bioanal. 
Chem. 382, 297–302.
G. Ocvirk, T. Tang, Harrison, D.J., 1998. Analyst 123, 1429.
Gehring, A.G., Irwin, P.L., Reed, S.A., Tu, S.-I., 2006. J. Rap. Meth. Autom. Microbiol. 
14, 349-361.
Gijs, M.A.M., Lacharme, F., Lehmann, U., 2010. Chem. Rev. 110, 1518–1563.
Godino, N., Snakenborg, D., Kutter, J.P., Emnéus, J., Hansen, M.F., Muñoz, F.X., del 
Campo, F.J., 2010. Microfluid Nanofluid 8, 393–402.
H. S. Hussein, Bollinger, L.M., 2005. J. Food Prot. 68, 2224-2241.
Herrmann, M., Veres, T., Tabrizian, M., 2008. Anal. Chem. 80, 5160-5167 
Hervas, M., Lopez, M.A., Escarpa, A., 2009. Analyst 134(12), 2405-2411.
Hsing, I.M., Xu, Y., Zhao, W.T., 2007. Electroanalysis 19(7-8), 755-768.
J. H. Thomas, N. J. Ronkainen-Matsuno, S. Farell, H. B. Halsall, Heineman, W.R., 
2003. Microchem. 74, 267-276.
Jaffrezic-Renault, N., Martelet, C., Chevolot, Y., Cloarec, J.P., 2007. Sensors 7(4), 589-
614.
Ji, X., Banks, C.E., Silvester, D.S., Wain, A.J., Compton, R.G., 2007. J. Phys. Chem. C 
111, 1496-1504
Johansson, L., Gunnarsson, K., Bijelovic, S., Eriksson, K., Surpi, A., Gothelid, E., 
Svedlindh, P., Oscarsson, S., 2010. Lab on a Chip 10(5), 654-661.
Kothary, M.H., Babu, U.S., 2001. J. Food Saf. 21(1), 49-73.
Laczka, O., Baldrich, E., del Campo, F.J., Muñoz , F.X., 2008. Anal. Bioanal. Chem. 
391, 2825–2835.
N. Beyor, T. S. Seo, P. Liu, Mathies, R.A., 2008. Microdevices 10, 909-917.
Nakamura, N., Burgess, J.G., Yagiuda, K., Kudo, S., Sakaguchi, T., Matsunaga, T., 
1993. Anal. Chem. 65(15), 2036-2039.
P. M. Griffin, Tauxe, R.V., 1991. Epidemiol. Rev 13, 60-98.
Peyman, S.A., Iles, A., Pamme, N., 2009. Lab on a Chip 9(21), 3110-3117.
Qiu, J.M., Zhou, Y., Chen, H., Lin, J.M., 2009. Talanta 79(3), 787-795.
Page 15 of 22
Ac
ce
pte
d M
an
us
cri
pt
15
Ramadan, Q., Christophe, L., Teo, W., ShuJun, L., Hua, F.H., 2010. Anal. Chim. Acta 
673(1), 101-108.
Rotariu, O., Ogden, I.D., MacRae, M., Badescu, V., Strachan, N.J.C.J., 2005. J. Magn. 
Magn. Mat. 293, 589.
Schmid, D., Fretz, R., Winter, P., Mann, M., Hoger, G., Stoger, A., Ruppitsch, W., 
Ladstatter, J., Mayer, N., de Martin, A., Allerberger, F., 2009. Wien. Klin. 
Wochen. 121(3-4), 125-131.
Straub, T.M., Dockendorff, B.P., Quinonez-Diaz, M.D., Valdez, C.O., Shutthanandan, 
J.I., Tarasevich, B.J., Grate, J.W., Bruckner-Lea, C.J., 2005. J. Microbiol. 
Methods 62(3), 303-316.
Tu, S.-I., Patterson, D., Briggs, C., Irwin, P., Yu, L., 2001. J. Indus. Microbiol. 
Biotechnol. 26, 345-349.
Tu, S.I., Golden, M., Fett, W.F., Gehring, A., Irwin, P., 2003. J. Food Saf. 23(2), 75-89.
Vasavada, P.C., 1988. J. Dairy Sci. 71(10), 2809-2816.
Volpe, G., Compagnone, D., Draisci, R., Palleschi, G., 1998. Analyst 123, 1303–1307.
Yoon, D.H., Ha, J.B., Bahk, Y.K., Arakawa, T., Shoji, S., Go, J.S., 2009. Lab on a Chip 
9(1), 87-90.
Yu, H., 1998. J. Immunol. Meth. 218, 1-8.
Yu, H., Raymonda, J.M., McMahon, T.M., Campagnari, A.A., 2000. Biosens. 
Bioelectron. 14, 829.
Page 16 of 22
Ac
ce
pte
d M
an
us
cri
pt
16
Figure legends
Figure 1. Scheme of the microfluidic system, which consists of three components. 
The bottom contains pockets to hold the chip and two magnets that promote MP 
confinement upstream from the electrode. The top closure features the fluidic 
interconnections and a pocket for the PDMS gasket. This gasket provides water-tight 
sealing and contains all the microfluidic features: a cavity 2 mm wide, 150 µm high 
and 5 mm long directly above the magnets, which is joined to a channel 500 µm 
wide, 150 µm high and 6.5 mm long that makes the solution pass over the 
electrodes. The microband gold electrodes consist of three bands 500 µm wide and 
one band 1 mm wide, all parallel and separated from each other by 100 µm gaps. 
The wider band was used as auxiliary electrode and the upstream-most microband 
was used as the pseudo-reference to avoid potential shifts during the measurements. 
The assay consists of the following steps: (1) Immunocapture of target bacteria with 
MP, labelling with HRP-Ab and injection in the microfluidic system. (2) Magnetic 
confinement of MP in the reaction chamber where enzyme reaction takes place. (3) 
Reduction of enzyme-produced BQ at the gold electrodes, downstream. The 
different biocomponents are not drawn to scale.
Figure 2. Optimisation of the sandwich immunoassay on MP. (a) Comparative 
performance of the two-step assay (■) and the 40-minute one-step approach (●). (b) 
Comparative performance of the one-step sandwich extended for 20 (▼), 40 (●), and 
60 minutes (▲). (c) Specificity of the one-step sandwich assay for E. coli (■) versus  
P. Putida (●).
Figure 3: Detection of HRP using the flow cell. (a) Chronoamperograms obtained 
over time for increasing concentrations of HRP captured on MP(1 mM of H2O2 and 
1 mM of HQ) (b) Calibration plot for the steady-state intensity current after 250 
seconds of measurement.
Figure 4: Calibration plot of the steady-state current registered after 250 seconds of 
measurement for increasing bacterial concentrations. (Inset) Examples of the 
chronoamperograms obtained for the different bacterial concentrations.
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Figure 5: Microfluidic detection in the absence (control) or in the presence of 100 E. 
coli cells ml-1 in either PBS or milk (10%). (Top) Values of the initial reduction peak 
(absolute values) and the steady state current obtained for 3 independent samples. 
(Bottom) Averaged peak currents. The inset shows an example of the 
chronoamperograms obtained in PBS (black line, negative control; grey line, E. coli).
By convention, negative signs indicate a reduction current. SD stands for standard 
deviation.
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